Senior Canadian stock market closed Monday with gains in all sectors except gold and items such as stock hair on the upper end of the trading range would be controlled from a seated mid-September. S & P / TSX Composite index ended up meeting until Monday 91.32, or 0.8 percent, to 11,554.72. After surging earlier in the month, the benchmark closed above 11,600 only once, from 3 December. Index shot up 53 percent from 9 March - when closing its lowest level in more than five years, and 16 September - when it reached 11,555.60. But the result of three months, after a series of dips and climbs, the market is essentially where it began.
To the south of the border, at the same time, rising U.S. dollar helped Wall Street to the Canadian market with the Dow Jones Industrial Average rising by 7.5 percent while the S & P 500 and the Nasdaq advanced four percent. On Monday, the Dow held the greatest progress in the month, rising 85.25 points, or 0.8 percent, to 10,414.14, while the S & P 500 rose 11.58, or one percent, to 1114.05 and the Nasdaq climbed 25.97, or 1.2 percent, to 2237.66, the highest level of the year. Health insurance companies all moved higher after U.S. Senate vote in the advance health care law contains a so-called public choice, in accordance with Connecticut Senator Joe Lieberman. Hartford-Aetna rose to $ 15.3, or 4.7 percent, to $ 34.04 U.S.. Wellpoint gained $ 1.70, or 2.9 percent, to $ 60.01 U.S.. Cigna added $ 1.39, or 3.9 percent, to $ 37.19 U.S.. French giant Sanofi Aventis Pharma agreed to pay 1.9 billion U.S. dollars for the purchase of marketing know-how Chatto, the makers of over-the-counter drugs, such as gold Bond itch powder and Selsun Blue dandruff. Chatto shares jumped $ 23.16, or 33 percent, to $ 93.14 U.S.. Sanofi closed four cents to $ 39.07 U.S..
The U.S. dollar rallied, and not something that's recently been in the days when the U.S. stock markets are making gains. The dollar reached its highest level against the euro in three and a half months. Despite the power of money we, the Canadian dollar added a four-tenth of a cent to 94.22 U.S. cents.
Gold showed the same resilience in the face of rising dollar, sinking $ 15.50, or 1.4 percent on Monday to address the U.S. $ 1100 for the first time since early November to U.S. $ 1096 per ounce. Most recently, the Canadian plains market can be traced to the price bars: Since gold has reached All-Time High at the beginning of December, trading more than U.S. $ 1200, S & P / TSX global gold index fell by 16 percent. But the overall Canadian market is down stocks of gold. Industrials and utilities climbed six percent in the same period, while the information technology sector, anchored marker Blackberry Research in Motion, which tacked on 10 percent. S & P / TSX Venture composite, which is home to more speculative junior mining exploration sector, is not observed decline in the index senior gold, sliding just 1.5 percent in the same time. On Monday tile Venture pulled two points at 1428.17. Crude oil slid Monday January contract shedding 89 cents, or 1.2 percent, to $ 72.47 U.S. per barrel. Gas decorated ten cents, or 1.8 percent, to $ 5.68 U.S. per one million BTU, for a strong time-driven rally last week.
Vancouver-shore Wholesale Appliances Income Fund rose 24 cents, or 5.5 percent, to $ 4.55, a new 52-week high. Suppliers of kitchen equipment for public works announced year-end cash distribution of 4.16 cents per unit, in addition to regular monthly distribution of equal value, to increase the annual harvest unit. OncoGenex tumbled $ 8.52, or 29 percent, to $ 21.13 U.S.. Hair by biotech company chief scientific officer, Dr. Martin Gleave, a researcher at UBC and BC Cancer Agency, undaunted by a licensing agreement with Teva Pharmaceuticals of Israel. Teva will fund the lion's share of future clinical trials in lung cancer and prostate cancer and to pay 60 million U.S. dollars in the U.S. in the initial charges, with $ 10 million-share repurchase and U.S. $ 37.38 per share. Some businessmen clearly expect a higher deposit in cash, or even a takeover bid. But the New York biotech ANALYST Simos Simeonidis said the agreement preserves the value OncoGenex in the form of royalties and future applications for alternative medicine.
To the south of the border, at the same time, rising U.S. dollar helped Wall Street to the Canadian market with the Dow Jones Industrial Average rising by 7.5 percent while the S & P 500 and the Nasdaq advanced four percent. On Monday, the Dow held the greatest progress in the month, rising 85.25 points, or 0.8 percent, to 10,414.14, while the S & P 500 rose 11.58, or one percent, to 1114.05 and the Nasdaq climbed 25.97, or 1.2 percent, to 2237.66, the highest level of the year. Health insurance companies all moved higher after U.S. Senate vote in the advance health care law contains a so-called public choice, in accordance with Connecticut Senator Joe Lieberman. Hartford-Aetna rose to $ 15.3, or 4.7 percent, to $ 34.04 U.S.. Wellpoint gained $ 1.70, or 2.9 percent, to $ 60.01 U.S.. Cigna added $ 1.39, or 3.9 percent, to $ 37.19 U.S.. French giant Sanofi Aventis Pharma agreed to pay 1.9 billion U.S. dollars for the purchase of marketing know-how Chatto, the makers of over-the-counter drugs, such as gold Bond itch powder and Selsun Blue dandruff. Chatto shares jumped $ 23.16, or 33 percent, to $ 93.14 U.S.. Sanofi closed four cents to $ 39.07 U.S..
The U.S. dollar rallied, and not something that's recently been in the days when the U.S. stock markets are making gains. The dollar reached its highest level against the euro in three and a half months. Despite the power of money we, the Canadian dollar added a four-tenth of a cent to 94.22 U.S. cents.
Gold showed the same resilience in the face of rising dollar, sinking $ 15.50, or 1.4 percent on Monday to address the U.S. $ 1100 for the first time since early November to U.S. $ 1096 per ounce. Most recently, the Canadian plains market can be traced to the price bars: Since gold has reached All-Time High at the beginning of December, trading more than U.S. $ 1200, S & P / TSX global gold index fell by 16 percent. But the overall Canadian market is down stocks of gold. Industrials and utilities climbed six percent in the same period, while the information technology sector, anchored marker Blackberry Research in Motion, which tacked on 10 percent. S & P / TSX Venture composite, which is home to more speculative junior mining exploration sector, is not observed decline in the index senior gold, sliding just 1.5 percent in the same time. On Monday tile Venture pulled two points at 1428.17. Crude oil slid Monday January contract shedding 89 cents, or 1.2 percent, to $ 72.47 U.S. per barrel. Gas decorated ten cents, or 1.8 percent, to $ 5.68 U.S. per one million BTU, for a strong time-driven rally last week.
Vancouver-shore Wholesale Appliances Income Fund rose 24 cents, or 5.5 percent, to $ 4.55, a new 52-week high. Suppliers of kitchen equipment for public works announced year-end cash distribution of 4.16 cents per unit, in addition to regular monthly distribution of equal value, to increase the annual harvest unit. OncoGenex tumbled $ 8.52, or 29 percent, to $ 21.13 U.S.. Hair by biotech company chief scientific officer, Dr. Martin Gleave, a researcher at UBC and BC Cancer Agency, undaunted by a licensing agreement with Teva Pharmaceuticals of Israel. Teva will fund the lion's share of future clinical trials in lung cancer and prostate cancer and to pay 60 million U.S. dollars in the U.S. in the initial charges, with $ 10 million-share repurchase and U.S. $ 37.38 per share. Some businessmen clearly expect a higher deposit in cash, or even a takeover bid. But the New York biotech ANALYST Simos Simeonidis said the agreement preserves the value OncoGenex in the form of royalties and future applications for alternative medicine.
No comments:
Post a Comment